Examining zoledronic acid for the prevention of bone loss in patients receiving bariatric surgery

Examining zoledronic acid for the prevention of bone loss in patients receiving bariatric surgery

Purpose: Bariatric surgery is an effective treatment for severe obesity but causes substantial bone loss and increased risk of fractures. To date, there have been no studies examining whether pharmacologic treatments can prevent bone loss after bariatric surgery. We performed an exploratory study to...

Full description

Bibliographic Details
Main Authors: Yi Liu, Maya M. Côté, Michael C. Cheney, Katherine G. Lindeman, Claire C. Rushin, Matthew M. Hutter, Elaine W. Yu
Format: Article
Language:English
Published: Elsevier 2021-06-01
Series:Bone Reports
Subjects:
Bariatric surgery
Gastric bypass
Bone loss
Zoledronic acid
Bisphosphonates
Bone turnover marker
Online Access:http://www.sciencedirect.com/science/article/pii/S2352187221000152

Internet

http://www.sciencedirect.com/science/article/pii/S2352187221000152

Similar Items